MIC-1/GDF15 in Barrett’s oesophagus and oesophageal adenocarcinoma
Open Access
- 17 March 2015
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 112 (8) , 1384-1391
Abstract
Biomarkers are needed to improve current diagnosis and surveillance strategies for patients with Barrett’s oesophagus (BO) and oesophageal adenocarcinoma (OAC). Macrophage inhibitory cytokine 1/growth differentiation factor 15 (MIC-1/GDF15) tissue and plasma levels have been shown to predict disease progression in other cancer types and was therefore evaluated in BO/OAC. One hundred thirty-eight patients were studied: 45 normal oesophagus (NE), 37 BO, 16 BO with low-grade dysplasia (LGD) and 40 OAC. Median tissue expression of MIC-1/GDF15 mRNA was 25-fold higher in BO and LGD compared to NE (Pvs BO (P=0.039); and 47-fold higher in OAC vs NE (P720 discriminated between the presence of either OAC or LGD vs NE with 94% sensitivity and 71% specificity (ROC AUC 0.86, 95% CI 0.73–0.96; Pvs NE (PP=0.015). High MIC-1/GDF15 plasma levels (1140 pg ml−1) were an independent predictor of poor survival for patients with OAC (HR 3.87, 95% CI 1.01–14.75; P=0.047). Plasma and tissue levels of MIC-1/GDF15 are significantly elevated in patients with BO, LGD and OAC. Plasma MIC-1/GDF15 may have value in diagnosis and monitoring of Barrett’s disease.Keywords
This publication has 50 references indexed in Scilit:
- Anorexia/cachexia of chronic diseases: a role for the TGF‐β family cytokine MIC‐1/GDF15Journal of Cachexia, Sarcopenia and Muscle, 2012
- Cigarette Smoking Increases Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma ConsortiumGastroenterology, 2012
- Screening for oesophageal cancerNature Reviews Clinical Oncology, 2012
- Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple MyelomaCancer Research, 2012
- Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancerBritish Journal of Cancer, 2011
- American Gastroenterological Association Technical Review on the Management of Barrett's EsophagusGastroenterology, 2011
- Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine‐1 in cancerJournal of Cellular Physiology, 2010
- Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancerBritish Journal of Cancer, 2010
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study DesignJNCI: Journal of the National Cancer Institute, 2008
- Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's EsophagusAmerican Journal of Epidemiology, 2005